VAR - Varian Medical Systems, Inc.
114.68 0.00 (0.00%)
After hours: 6:05PM EDT
| Previous Close | 116.32 |
| Open | 116.63 |
| Bid | 111.00 x 800 |
| Ask | 114.59 x 1200 |
| Day's Range | 114.17 - 117.08 |
| 52 Week Range | 101.42 - 142.50 |
| Volume | 537,568 |
| Avg. Volume | 720,915 |
| Market Cap | 10.443B |
| Beta (3Y Monthly) | 0.93 |
| PE Ratio (TTM) | 31.21 |
| EPS (TTM) | 3.67 |
| Earnings Date | Oct 23, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | 1998-12-02 |
| 1y Target Est | 139.06 |
- Zacks
Quest Diagnostics (DGX) Q3 Earnings Surpass, View Strong
We are upbeat about Quest Diagnostics' (DGX) expanded network access, which assists the company to accelerate volume growth in Q3.
- Zacks
Medical Products' Earnings Roster for Oct 23: TMO, BSX & More
Encouraging growth in the emerging markets despite the ongoing trade tiff is likely to contribute to revenues in the medical products space this earnings season.
- Zacks
3 Medical Product Stocks Likely to Beat This Earnings Season
Here we discuss three medical product stocks that are due to report soon and are likely to beat estimates on earnings, riding on a host of factors.
- Zacks
Intuitive Surgical (ISRG) Beats on Q3 Earnings, View Solid
Intuitive Surgical (ISRG) gains from solid segmental contributions in Q3.
- Zacks
What's in Store for Varian Medical (VAR) in Q4 Earnings?
Varian (VAR) is expected to have gained from core Proton Therapy platform in fiscal Q4.
- Zacks
Go Beyond Bargains: Play 5 Stocks With Rising P/E Instead
Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.
- Zacks
Abbott (ABT) Meets Q3 Earnings Estimates, Lowers EPS Guidance
We are optimistic about Abbott's (ABT) strong and consistent EPD and Medical Devices performance organically.
- Zacks
Tandem Rides on Strong t:slim X2 Rollout Amid Stiff Rivalry
Tandem Diabetes (TNDM) gains on strong domestic sales along with a solid international rollout of the t:slim X2 insulin pump.
- Zacks
QIAGEN (QGEN) Launches QIAseq FastSelect Technology Kits
The launch of the kits is expected to bolster QIAGEN's (QGEN) Life Sciences Business Area
- American City Business Journals
Children’s, UC Health hit milestone in 1-second cancer treatment
The Proton Therapy Center operated by Cincinnati Children’s Hospital and UC Health has hit a significant milestone in researching the use of high doses of proton beams delivered at ultra-high speeds to treat cancer.
- Zacks
Edwards Lifesciences Hits a 52-Week High on Solid Prospects
Edwards Lifesciences (EW) has been consistently delivering impressive results.
- Zacks
Here's Why You Should Retain Henry Schein (HSIC) Stock Now
Investor confidence is still high on Henry Schein (HSIC), thanks to solid prospects.
- PR Newswire
Varian and Cincinnati Children's Hospital Medical Center/University of Cincinnati Medical Center Proton Therapy Center Achieve Significant Milestone in Research of FLASH Therapy
PALO ALTO, Calif. , Oct. 14, 2019 /PRNewswire/ -- Varian (NYSE: VAR) in collaboration with Cincinnati Children's Hospital Medical Center/ University of Cincinnati Medical Center Proton Therapy Center announced ...
- Insider Monkey
Is Varian Medical Systems, Inc. (VAR) A Good Stock To Buy?
While the market driven by short-term sentiment influenced by the accomodative interest rate environment in the US, increasing oil prices and deteriorating expectations towards the resolution of the trade war with China, many smart money investors kept their cautious approach regarding the current bull run in the second quarter and hedging or reducing many of […]
- Zacks
Here's Why You Should Add Stryker (SYK) to Your Portfolio Now
Stryker's (SYK) core Mako Platform has been consistently driving its top line.
- Zacks
DexCom's (DXCM) New G6 Pro CGM System Gets FDA Approval
FDA approval for DexCom's (DXCM) G6 Pro boosts the company's broad product spectrum.
- PR Newswire
Varian Highlights Interventional Oncology Solutions at CIO Symposium
PALO ALTO, Calif. , Oct. 8, 2019 /PRNewswire/ -- Varian (NYSE: VAR) will showcase the company's interventional oncology solutions at the Symposium on Clinical Interventional Oncology, October 11-13, 2019 ...
- Zacks
Stryker Gains From Flagship Mako and Broad Product Spectrum
Stryker's (SYK) broad product spectrum cushions the company from any significant sales shortfall.
- Zacks
5 Excellent GARP Picks Based on Discounted PEG
While P/E gives an idea of stocks trading at a discount, PEG helps to find stocks with solid future potential.
- Zacks
AngioDynamics (ANGO) Q1 Earnings Top, Revenues Lag Estimates
AngioDynamics (ANGO) keeps fiscal 2020 revenue guidance intact, slashes EPS view.
- Thomson Reuters StreetEvents
Edited Transcript of VAR earnings conference call or presentation 24-Jul-19 8:30pm GMT
Q3 2019 Varian Medical Systems Inc Earnings Call
- Simply Wall St.
Should You Worry About Varian Medical Systems, Inc.'s (NYSE:VAR) CEO Pay?
Dow Wilson has been the CEO of Varian Medical Systems, Inc. (NYSE:VAR) since 2012. This report will, first, examine...
- Zacks
The Zacks Analyst Blog Highlights: Varian, Stryker and Medtronic
The Zacks Analyst Blog Highlights: Varian, Stryker and Medtronic
- Zacks
3 MedTech Stocks in Focus on Emerging Market Prospects
Emerging market countries present lucrative prospects; consequently, investors can take a look at the space.
- Zacks
Here's Why You Should Hold Onto Cerner (CERN) Stock for Now
Cerner (CERN) keeps its 2019 revenue guidance intact; expects improvement in bookings.
